El tratamiento con quimioterapia hoy en pacientes HER2 negativo: el papel de la eribulina - page 40

Phase Ib/II study of

eribulin

plus

pembrolizumab

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,30,31,32,33,34,35,36,37,38,39 41,42,43